Historical record - last NADAC effective date: 6/21/2023
Strength
262 mg/1
Manufacturer
CDMA- QCNDC
63868062230
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
6/21/2023
Active Ingredients
BISMUTH SUBSALICYLATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M008On Market Since
12/23/2014
Pharmacological Classes
Price Statistics
The NADAC for QC STOMACH RLF 262 MG CHEW TAB has been published 23 times since Jan 25, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0744 per EA |
|---|---|
| All-time high | $0.0764 (May 10, 2023) |
| All-time low | $0.0694 (Mar 22, 2023) |
| Median price | $0.0741 |
| Average price | $0.0735 |
| Largest weekly change | +10.0% (Apr 19, 2023) |
| Weeks tracked | 23 |
| Tracking since | Jan 25, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-0.1%
Last surveyed Jun 28, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
CDMA- QC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bismuth Subsalicylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bismuth class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC STOMACH RLF 262 MG CHEW TAB?
The current National Average Drug Acquisition Cost (NADAC) for QC STOMACH RLF 262 MG CHEW TAB, manufactured by CDMA- QC, is $0.0744 per EA (NDC 63868062230), effective Jun 28, 2023.
How has the price of QC STOMACH RLF 262 MG CHEW TAB changed over time?
Over the history we have for it, the NADAC for QC STOMACH RLF 262 MG CHEW TAB has held within roughly two percent of its current level. It has been tracked across 23 weekly CMS publications since Jan 25, 2023.
What are the highest and lowest recorded NADAC prices for QC STOMACH RLF 262 MG CHEW TAB?
Since Jan 25, 2023, the NADAC for QC STOMACH RLF 262 MG CHEW TAB has ranged from a low of $0.0694 (Mar 22, 2023) to a high of $0.0764 (May 10, 2023), with a median of $0.0741 per EA.
Are there cheaper alternatives to QC STOMACH RLF 262 MG CHEW TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BISMUTH 262 MG TABLET CHEW, is $0.0666 per EA — about 10% below QC STOMACH RLF 262 MG CHEW TAB.
Who manufactures QC STOMACH RLF 262 MG CHEW TAB?
QC STOMACH RLF 262 MG CHEW TAB (NDC 63868062230) is labeled by CDMA- QC, and CMS classifies it as a generic product.